DOI:
10.1055/s-00000131
Synfacts
LinksClose Window
References
Pierce ME. * Chen C.-y. * Tillyer RD. * et al. The DuPont Pharmaceuticals Company, Deepwater and Merck Research Laboratories, Rahway, USA
Practical Asymmetric Synthesis of Efavirenz (DMP 266), an HIV-1 Reverse Transcriptase Inhibitor.
J. Org. Chem. 1998;
63: 8536-8543
Access:
We do not assume any responsibility for the contents of the web pages of other providers.